Star STFS Active Stock STFS Earnings Star withholds core financial metrics amid retail headwinds Praetorian PTOR Stock Price Target Cut 010 20260420 EQR Equity handily beats Q4 2025 earnings estimates shares rise 12 percent on 38 percent year over year revenue growth Celldex CLDX Stock Is It Reasonably Valued Q4 2025 Profit Disappoints VRSK Verisk Analytics Q4 2025 earnings outperform expectations shares tick higher on steady year over year revenue growth JKHY Jack Henry delivers 178 percent Q1 2026 EPS beat shares rise slightly on positive results ARBK Argo Blockchain reports Q2 2024 019 dollar per share loss and 159 revenue drop shares fall 347 Gilead Sciences Inc GILD NXG NXG quarterly earnings disclosures offer limited operational details with full updates slated for next week CRH PLC CRH Stock Free Float Touches High 20260420 Dollar Tree Inc DLTR Bearish Outlook Amid Escalating US Consumer Spending Pressures From Geopolitical Energy Shocks Is Saba Capital BRW stock forming a reversal pattern BRW Latest Quarter Earnings Saba Capital posts solid private credit gains Is Interactive Strength TRNR stock testing resistance Q4 2025 Earnings Underperform Where is Conoco COP stock heading next Smart Money Active 20260420 Waystar Holding WAY Stock Is It a Smart Buy Smart Money Active 20260420 Honeywell International Inc HON Reshapes Aerospace Portfolio and Advances Planned Q3 2026 ThreeWay Separation Is Vontier Corporation VNT stock worth adding exposure to Q4 2025 EPS Beats Forecasts Is Banco Macro BMA stock fading in strength Q4 2025 Profit Exceeds Views Does Descartes DSGX stock carry significant risk Q1 2026 EPS Beats Forecasts What factors are influencing Immersion Corporation IMMR stock today Weakens 20260427 HRL Hormel tops Q1 2026 EPS estimates and posts mild revenue growth shares rise slightly in todays session Hyperscale Data GPUS Stock Initiates Position Investor Concern 20260420 Atossa ATOS Stock What Is Driving the Price Q4 2025 Below Expectations TRX Gold TRX posts steep Q1 2026 EPS shortfall versus estimates with shares flat after earnings release REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates shares end flat for the trading day